[Inhibition of small intestine motility by orally administered hyoscine-N-butylbromide].
D000328:Adult; D003864:Depression, Chemical; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D007421:Intestine, Small / Q000187:drug effects*; D008297:Male; D010919:Placebos; D011342:Procainamide / Q000037:antagonists & inhibitors*; D012601:Scopolamine / Q000494:pharmacology*
D010919:Placebos; D012601:Scopolamine; D011342:Procainamide
Hemmung der Dünndarmmotorik durch oral appliziertes Hyoscin-N-butylbromid.